Report Categories
View AllRecent Articles
View All
What Should Investors Watch In Fg Nexus Fgnx Stock Fgnx Q3 2025 Earnings Fg Nexus Inc. Reports 7.6 Eps Vs 0.612 Est No Revenue 20260408 1
Does Altimmune Alt Stock Pay Reliable Income Price At 3.21 Down 0.93 20260413
Can Ultralife Corporation Ulbi Stock Recover Now Price At 6.74 Up 0.90 20260406
How Does Earnings Affect Commvault Cvlt Stock Price At 80.73 Up 1.94 20260408
Can Enovix Corporation Envx Stock Reach New Highs Envx Q4 2025 Earnings Enovix Corporation Beats Eps Views No Q4 Revenue 20260408 1
Can Milestone Mist Stock Reach New Highs Price At 1.95 Down 3.47 20260413
Is Precision Poci Stock Worth Buying Now Price At 4.00 Down 6.32 20260406
Is Mueller Mwa Stock Heavily Shorted Price At 29.47 Up 1.48 20260409
Is Redwood Trust Rwt Stock Good For Active Traders Price At 5.71 Up 0.88 20260406
NXTT Next management signals ongoing AI integration investments to boost longterm operating efficiency across all segments
Why Ridgepost Capital RPC could be the turning point youve been waiting for At Lows 20260506
Is Auto Data ADP stock a good investment this year Q1 2026 Earnings Beat Estimates
Toyota Motor Corporation TM Fuel Cell Commercial Vehicle Partnership Positions Stock as a Top Japanese Equity Pick
HEPS DMarket posts negative Q4 2025 quarterly earnings as its stock notches a small gain in daily trading
KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss
Why Oak Woods OAKU cost structure is getting attention OAKU Q1 2025 Oak Woods Posts 081 EPS Zero Revenue
IBO Impact BioMedical quarterly earnings report shows no revenue or EPS data disclosed investors await additional details
CPBI Cent Plains reports 103 revenue growth in Q2 2025 shares rise on solid quarterly performance
How MacroGenics MGNX innovation pipeline shows in financials MGNX MacroGenics Q4 Earnings Beat Shrinks Loss by 22
How Blueport BPAC pricing power shows up in earnings BPAC Q3 Earnings Blueport Reports No Revenue Data
Regeneron Pharmaceuticals REGN Reports Mixed Q1 2026 Results As GAAP Net Income Declines 10 Amid Rising Operating Costs